{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T10:04:46Z","timestamp":1789639486600,"version":"4.0.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2022J011092"],"award-info":[{"award-number":["2022J011092"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2022Y0064"],"award-info":[{"award-number":["2022Y0064"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s13346-024-01726-3","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T19:01:54Z","timestamp":1729623714000},"page":"2087-2098","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Development of FK506-loaded maleimide-functionalized cationic niosomes for prolonged retention and therapeutic efficacy in dry eye disease"],"prefix":"10.1007","volume":"15","author":[{"given":"Zhixin","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiansheng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianquan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,22]]},"reference":[{"key":"1726_CR1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.bioactmat.2021.07.027","volume":"9","author":"H Yi","year":"2022","unstructured":"Yi H, et al. Effectiveness of an ocular adhesive polyhedral oligomeric silsesquioxane hybrid thermo-responsive FK506 hydrogel in a murine model of dry eye. Bioactive Mater. 2022;9:77\u201391. https:\/\/doi.org\/10.1016\/j.bioactmat.2021.07.027.","journal-title":"Bioactive Mater"},{"key":"1726_CR2","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.actbio.2023.12.021","volume":"175","author":"L Ou","year":"2024","unstructured":"Ou L, et al. A tissue-adhesive F127 hydrogel delivers antioxidative copper-selenide nanoparticles for the treatment of dry eye disease. Acta Biomater. 2024;175:353\u201368. https:\/\/doi.org\/10.1016\/j.actbio.2023.12.021.","journal-title":"Acta Biomater"},{"key":"1726_CR3","doi-asserted-by":"publisher","unstructured":"Stapleton F, TFOS DEWS II Epidemiology Report, et al. Ocul Surf. 2017;15:334\u201365. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.003.","DOI":"10.1016\/j.jtos.2017.05.003"},{"key":"1726_CR4","doi-asserted-by":"publisher","first-page":"112255","DOI":"10.1016\/j.colsurfb.2021.112255","volume":"211","author":"D Modi","year":"2022","unstructured":"Modi D, et al. Formulation and development of tacrolimus-gellan gum nanoformulation for treatment of dry eye disease. Colloids Surf B Biointerfaces. 2022;211:112255. https:\/\/doi.org\/10.1016\/j.colsurfb.2021.112255.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"10","key":"1726_CR5","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.3390\/pharmaceutics13101698","volume":"13","author":"A L\u00f3pez-Machado","year":"2021","unstructured":"L\u00f3pez-Machado A, et al. Development of lactoferrin-loaded liposomes for the management of Dry Eye Disease and ocular inflammation. Pharmaceutics. 2021;13(10):1698. https:\/\/doi.org\/10.3390\/pharmaceutics13101698.","journal-title":"Pharmaceutics"},{"key":"1726_CR6","doi-asserted-by":"publisher","unstructured":"Kojima T, et al. Advances in the diagnosis and treatment of dry eye. Prog Retin Eye Res. 2020;100842. https:\/\/doi.org\/10.1016\/j.preteyeres.","DOI":"10.1016\/j.preteyeres"},{"key":"1726_CR7","doi-asserted-by":"publisher","unstructured":"Mohamed HB, et al. Current trends in pharmaceutical treatment of dry eye disease: a review. Eur J Pharm Sci. 2022;175:106206. https:\/\/doi.org\/10.1016\/j.ejps.2022.106206.","DOI":"10.1016\/j.ejps.2022.106206"},{"key":"1726_CR8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jtos.2021.04.011","volume":"21","author":"JS Wolffsohn","year":"2021","unstructured":"Wolffsohn JS, et al. Clinical practice patterns in the management of dry eye disease: a TFOS international survey. Ocul Surf. 2021;21:78\u201386. https:\/\/doi.org\/10.1016\/j.jtos.2021.04.011.","journal-title":"Ocul Surf"},{"key":"1726_CR9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.clae.2015.04.004","volume":"38","author":"BK Moscovici","year":"2015","unstructured":"Moscovici BK, et al. Treatment of Sj\u00f6gren\u2019s syndrome dry eye using 0.03% tacrolimus eye drop: prospective double-blind randomized study. Cont Lens Anterior Eye. 2015;38:373\u20138. https:\/\/doi.org\/10.1016\/j.clae.2015.04.004.","journal-title":"Cont Lens Anterior Eye"},{"issue":"6","key":"1726_CR10","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/aos.12675","volume":"93","author":"V Lloren\u00e7","year":"2015","unstructured":"Lloren\u00e7 V, et al. Epidemiology of uveitis in a western urban multiethnic population. The challenge of globalization. Acta Ophthalmol. 2015;93(6):561\u20137. https:\/\/doi.org\/10.1111\/aos.12675.","journal-title":"Acta Ophthalmol"},{"key":"1726_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11095-018-2556-5","volume":"36","author":"A Mandal","year":"2019","unstructured":"Mandal A, et al. Ocular pharmacokinetics of a Topical Ophthalmic Nanomicellar Solution of Cyclosporine (Cequa\u00ae) for Dry Eye Disease. Pharm Res. 2019;36:36. https:\/\/doi.org\/10.1007\/s11095-018-2556-5.","journal-title":"Pharm Res"},{"key":"1726_CR12","doi-asserted-by":"publisher","first-page":"105229","DOI":"10.1016\/j.ejps.2020.105229","volume":"144","author":"J Zhang","year":"2020","unstructured":"Zhang J, et al. Cationic nanoemulsions with prolonged retention time as promising carriers for ophthalmic delivery of tacrolimus. Eur J Pharm Sci. 2020;144:105229. https:\/\/doi.org\/10.1016\/j.ejps.2020.105229.","journal-title":"Eur J Pharm Sci"},{"key":"1726_CR13","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jconrel.2021.03.035","volume":"333","author":"L Rebibo","year":"2021","unstructured":"Rebibo L, et al. Topical tacrolimus nanocapsules eye drops for therapeutic effect enhancement in both anterior and posterior ocular inflammation models. J Control Release. 2021;333:283\u201397. https:\/\/doi.org\/10.1016\/j.jconrel.2021.03.035.","journal-title":"J Control Release"},{"key":"1726_CR14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.sjopt.2019.04.001","volume":"33","author":"SF Fiorentini","year":"2019","unstructured":"Fiorentini SF, Khurram D. Therapeutic effects of topical 0.03% tacrolimus ointment in children with refractory vernal keratoconjunctivitis in Middle East. Saudi J Ophthalmol. 2019;33:117\u201320. https:\/\/doi.org\/10.1016\/j.sjopt.2019.04.001.","journal-title":"Saudi J Ophthalmol"},{"key":"1726_CR15","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.2147\/ijn.S44487","volume":"8","author":"Y Dai","year":"2013","unstructured":"Dai Y, et al. Liposomes containing bile salts as novel ocular delivery systems for tacrolimus (FK506): in vitro characterization and improved corneal permeation. Int J Nanomed. 2013;8:1921\u201333. https:\/\/doi.org\/10.2147\/ijn.S44487.","journal-title":"Int J Nanomed"},{"key":"1726_CR16","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1167\/iovs.09-4373","volume":"51","author":"R Zhang","year":"2010","unstructured":"Zhang R, et al. Treatment of experimental autoimmune uveoretinitis with intravitreal injection of tacrolimus (FK506) encapsulated in liposomes. Invest Ophthalmol Vis Sci. 2010;51:3575\u201382. https:\/\/doi.org\/10.1167\/iovs.09-4373.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1726_CR17","doi-asserted-by":"publisher","first-page":"791954","DOI":"10.3389\/fbioe.2021.791954","volume":"9","author":"X Lin","year":"2021","unstructured":"Lin X, et al. Inhibition of Neovascularization and inflammation in a mouse model of corneal Alkali Burns using Cationic Liposomal Tacrolimus. Front Bioeng Biotechnol. 2021;9:791954. https:\/\/doi.org\/10.3389\/fbioe.2021.791954.","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"1726_CR18","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3390\/pharmaceutics14010118","volume":"14","author":"M Barrieu","year":"2022","unstructured":"Barrieu M, et al. Physicochemical Stability of a Novel Tacrolimus Ophthalmic Formulation for the treatment of Ophthalmic Inflammatory diseases. Pharmaceutics. 2022;14(1):118. https:\/\/doi.org\/10.3390\/pharmaceutics14010118.","journal-title":"Pharmaceutics"},{"key":"1726_CR19","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1080\/10717544.2019.1582728","volume":"26","author":"Q Wu","year":"2019","unstructured":"Wu Q, et al. Development and effects of tacrolimus-loaded nanoparticles on the inhibition of corneal allograft rejection. Drug Deliv. 2019;26:290\u20139. https:\/\/doi.org\/10.1080\/10717544.2019.1582728.","journal-title":"Drug Deliv"},{"key":"1726_CR20","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ejps.2019.03.023","volume":"133","author":"D Liu","year":"2019","unstructured":"Liu D, et al. Tacrolimus-loaded methoxy poly (ethylene glycol)-block-poly (D, L)-lactic-co-glycolic acid micelles self-assembled in aqueous solution for treating cornea immune rejection after allogenic penetrating keratoplasty in rats. Eur J Pharm Sci. 2019;133:104\u201314. https:\/\/doi.org\/10.1016\/j.ejps.2019.03.023.","journal-title":"Eur J Pharm Sci"},{"key":"1726_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2019.03.022","volume":"562","author":"D Liu","year":"2019","unstructured":"Liu D, et al. A novel FK506 loaded nanomicelles consisting of amino-terminated poly (ethylene glycol)-block-poly (D, L)-lactic acid and hydroxypropyl methylcellulose for ocular drug delivery. Int J Pharm. 2019;562:1\u201310. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.03.022.","journal-title":"Int J Pharm"},{"key":"1726_CR22","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/10837450.2022.2067870","volume":"27","author":"J Sun","year":"2022","unstructured":"Sun J, Sun X. Preparation of a novel tacrolimus ion sensitive ocular in situ gel and in vivo evaluation of curative effect of immune conjunctivitis. Pharm Dev Technol. 2022;27:399\u2013405. https:\/\/doi.org\/10.1080\/10837450.2022.2067870.","journal-title":"Pharm Dev Technol"},{"key":"1726_CR23","doi-asserted-by":"publisher","first-page":"120364","DOI":"10.1016\/j.ijpharm.2021","volume":"599","author":"MY Badr","year":"2021","unstructured":"Badr MY, et al. A polymeric aqueous tacrolimus formulation for topical ocular delivery. Int J Pharm. 2021;599:120364. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.","journal-title":"Int J Pharm"},{"key":"1726_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ejps.2018.03.034","volume":"119","author":"E Ramsay","year":"2018","unstructured":"Ramsay E, et al. Corneal and conjunctival drug permeability: systematic comparison and pharmacokinetic impact in the eye. Eur J Pharm Sci. 2018;119:83\u20139. https:\/\/doi.org\/10.1016\/j.ejps.2018.03.034.","journal-title":"Eur J Pharm Sci"},{"key":"1726_CR25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1208\/s12249-021-01977-0","volume":"22","author":"OL Lanier","year":"2021","unstructured":"Lanier OL, et al. Review of approaches for increasing Ophthalmic Bioavailability for Eye Drop formulations. AAPS PharmSciTech. 2021;22:107. https:\/\/doi.org\/10.1208\/s12249-021-01977-0.","journal-title":"AAPS PharmSciTech"},{"key":"1726_CR26","doi-asserted-by":"publisher","first-page":"6581","DOI":"10.1039\/c6tb02124g","volume":"4","author":"P Tonglairoum","year":"2016","unstructured":"Tonglairoum P, et al. Maleimide-bearing nanogels as novel mucoadhesive materials for drug delivery. J Mater Chem B. 2016;4:6581\u20137. https:\/\/doi.org\/10.1039\/c6tb02124g.","journal-title":"J Mater Chem B"},{"key":"1726_CR27","doi-asserted-by":"publisher","unstructured":"Roman.V.M, et al. Maleimide-Decorated PEGylated Mucoadhesive Liposomes for Ocular Drug Delivery, Langmuir, 2022; 38(45):13870\u201313879. https:\/\/doi.org\/10.1021\/acs.langmuir.2c02086","DOI":"10.1021\/acs.langmuir.2c02086"},{"issue":"17","key":"1726_CR28","doi-asserted-by":"publisher","first-page":"9668","DOI":"10.3390\/ijms23179668","volume":"23","author":"BA Witika","year":"2022","unstructured":"Witika BA, et al. Current advances in specialised Niosomal Drug Delivery: manufacture, characterization and drug delivery applications. Int J Mol Sci. 2022;23(17):9668. https:\/\/doi.org\/10.3390\/ijms23179668.","journal-title":"Int J Mol Sci"},{"key":"1726_CR29","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cis.2012.08.002","volume":"183\u2013184","author":"NB Mahale","year":"2012","unstructured":"Mahale NB, et al. Niosomes: novel sustained release nonionic stable vesicular systems\u2013an overview. Adv Colloid Interface Sci. 2012;183\u2013184:46\u201354. https:\/\/doi.org\/10.1016\/j.cis.2012.08.002.","journal-title":"Adv Colloid Interface Sci"},{"key":"1726_CR30","doi-asserted-by":"publisher","first-page":"121878","DOI":"10.1016\/j.ijpharm.2022.121878","volume":"624","author":"S Yasamineh","year":"2022","unstructured":"Yasamineh S, et al. A state-of-the-art review on the recent advances of niosomes as a targeted drug delivery system. Int J Pharm. 2022;624:121878. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.121878.","journal-title":"Int J Pharm"},{"key":"1726_CR31","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.biomaterials.2015.11.017","volume":"77","author":"E OJEDA","year":"2016","unstructured":"OJEDA E, et al. The influence of the polar head-group of synthetic cationic lipids on the transfection efficiency mediated by niosomes in rat retina and brain. Biomaterials. 2016;77:267\u201379. https:\/\/doi.org\/10.1016\/j.biomaterials.2015.11.017.","journal-title":"Biomaterials"},{"key":"1726_CR32","doi-asserted-by":"publisher","unstructured":"D. ZHI, et al. A review on cationic lipids with different linkers for gene delivery. Adv Colloid Interface Sci. 2018; 253: 117\u201340. https:\/\/doi.org\/10.1016\/j.cis.2017.12.006","DOI":"10.1016\/j.cis.2017.12.006"},{"key":"1726_CR33","doi-asserted-by":"publisher","first-page":"118238","DOI":"10.1016\/j.cis.2017.12.006","volume":"268","author":"SA Fereig","year":"2021","unstructured":"Fereig SA, et al. Tacrolimus-loaded chitosan nanoparticles for enhanced skin deposition and management of plaque psoriasis. Carbohydr Polym. 2021;268:118238. https:\/\/doi.org\/10.1016\/j.cis.2017.12.006.","journal-title":"Carbohydr Polym"},{"key":"1726_CR34","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.carbpol.2021.118238","volume":"157","author":"V Garg","year":"2017","unstructured":"Garg V, et al. Proglycosomes: a novel nano-vesicle for ocular delivery of tacrolimus. Colloids Surf B Biointerfaces. 2017;157:40\u20137. https:\/\/doi.org\/10.1016\/j.carbpol.2021.118238.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"1726_CR35","doi-asserted-by":"publisher","first-page":"1700455","DOI":"10.1002\/advs.201700455","volume":"5","author":"YH Weng","year":"2018","unstructured":"Weng YH, et al. Nanomicelle-assisted targeted ocular delivery with enhanced antiinflammatory efficacy in vivo. Adv Sci (Weinh). 2018;5:1700455. https:\/\/doi.org\/10.1002\/advs.201700455.","journal-title":"Adv Sci (Weinh)"},{"key":"1726_CR36","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.exer.2014.01.006","volume":"120","author":"K Kinnunen","year":"2014","unstructured":"Kinnunen K, et al. Cationorm shows good tolerability on human HCE-2 corneal epithelial cell cultures. Exp Eye Res. 2014;120:82\u20139. https:\/\/doi.org\/10.1016\/j.exer.2014.01.006.","journal-title":"Exp Eye Res"},{"key":"1726_CR37","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.actbio.2019.08.035","volume":"99","author":"G Tan","year":"2019","unstructured":"Tan G, et al. Phenylboronic acid-tethered chondroitin sulfate-based mucoadhesive nanostructured lipid carriers for the treatment of dry eye syndrome. Acta Biomater. 2019;99:350\u201362. https:\/\/doi.org\/10.1016\/j.actbio.2019.08.035.","journal-title":"Acta Biomater"},{"key":"1726_CR38","doi-asserted-by":"publisher","first-page":"103654","DOI":"10.1016\/j.jddst.2022.103654","volume":"75","author":"H Qiao","year":"2022","unstructured":"Qiao H, et al. Rebamipide liposome as an effective ocular delivery system for the management of dry eye disease. J Drug Deliv Sci Technol. 2022;75:103654. https:\/\/doi.org\/10.1016\/j.jddst.2022.103654.","journal-title":"J Drug Deliv Sci Technol"},{"key":"1726_CR39","doi-asserted-by":"publisher","first-page":"106020","DOI":"10.1016\/j.ejps.2021.106020","volume":"167","author":"Q Li","year":"2021","unstructured":"Li Q, et al. Preparation and characterization of a naringenin solubilizing glycyrrhizin nanomicelle ophthalmic solution for experimental dry eye disease. Eur J Pharm Sci. 2021;167:106020. https:\/\/doi.org\/10.1016\/j.ejps.2021.106020.","journal-title":"Eur J Pharm Sci"},{"key":"1726_CR40","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.colsurfb.2019.01.018","volume":"176","author":"P Niamprem","year":"2019","unstructured":"Niamprem P, et al. Penetration of Nile red-loaded nanostructured lipid carriers (NLCs) across the porcine cornea. Colloids Surf B Biointerfaces. 2019;176:371\u20138. https:\/\/doi.org\/10.1016\/j.colsurfb.2019.01.018.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"7","key":"1726_CR41","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.3390\/ijms18071558","volume":"18","author":"GA GEORGIEV","year":"2017","unstructured":"GEORGIEV GA, et al. Surface Chemistry Interactions of Cationorm with films by Human Meibum and tear Film compounds. Int J Mol Sci. 2017;18(7):1558. https:\/\/doi.org\/10.3390\/ijms18071558.","journal-title":"Int J Mol Sci"},{"key":"1726_CR42","doi-asserted-by":"publisher","first-page":"2184312","DOI":"10.1080\/10717544.2023.2184312","volume":"30","author":"H Li","year":"2023","unstructured":"Li H, et al. Physicochemical properties and micro-interaction between micro-nanoparticles and anterior corneal multilayer biological interface film for improving drug delivery efficacy: the transformation of tear film turnover mode. Drug Deliv. 2023;30:2184312. https:\/\/doi.org\/10.1080\/10717544.2023.2184312.","journal-title":"Drug Deliv"},{"issue":"6","key":"1726_CR43","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3390\/nano10061191","volume":"10","author":"S Durak","year":"2020","unstructured":"Durak S, et al. Niosomal Drug Delivery Systems for Ocular Disease-recent advances and future prospects. Nanomaterials (Basel). 2020;10(6):1191. https:\/\/doi.org\/10.3390\/nano10061191.","journal-title":"Nanomaterials (Basel)"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-024-01726-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-024-01726-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-024-01726-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T12:51:06Z","timestamp":1745844666000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-024-01726-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,22]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["1726"],"URL":"https:\/\/doi.org\/10.1007\/s13346-024-01726-3","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,22]]},"assertion":[{"value":"7 October 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal experiments were approved by the 900 Hospital of the Joint Logistics Team Animal Care and Use Committee (Approval number 2022-039).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agreed with the content and all gave explicit consent to submit the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that might influence the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}